Evidence map›Paper›PMID 24665145›Full record

ArticleDisease markers2014

RBP4 gene variants are associated with insulin resistance in women with previous gestational diabetes.

Renata Saucedo, Arturo Zarate, Lourdes Basurto, Marcelino Hernandez, Edgardo Puello, Patricia Mendoza-Lorenzo, Patricia Ostrosky-Wegman

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Relationships ofBioMed research international · 2019
    Article
  9. Molecular Biomarkers for Gestational Diabetes Mellitus.International journal of molecular sciences · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Renata SaucedoEndocrine Research Unit, National Medical Center, Mexican Social Security Institute, 06720 Mexico City, MX, Mexico.ORCID 0000-0001-5167-6156
Arturo ZarateEndocrine Research Unit, National Medical Center, Mexican Social Security Institute, 06720 Mexico City, MX, Mexico.ORCID 0000-0003-3606-0390
Lourdes BasurtoEndocrine Research Unit, National Medical Center, Mexican Social Security Institute, 06720 Mexico City, MX, Mexico.ORCID 0000-0002-2991-0433
Marcelino HernandezEndocrine Research Unit, National Medical Center, Mexican Social Security Institute, 06720 Mexico City, MX, Mexico.
Edgardo PuelloHospital of Gynecology and Obstetrics, Medical Center La Raza, Mexican Social Security Institute, 02990 Mexico City, MX, Mexico.
Patricia Mendoza-LorenzoDepartment of Genomic Medicine and Environmental Toxicology, Instituto de Investigaciones Biomedicas, Autonomous National University of Mexico, 04510 Mexico City, MX, Mexico.ORCID 0000-0002-0395-1122
Patricia Ostrosky-WegmanDepartment of Genomic Medicine and Environmental Toxicology, Instituto de Investigaciones Biomedicas, Autonomous National University of Mexico, 04510 Mexico City, MX, Mexico.
Mexican Social Security Institute · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis study aimed to examine possible genetic effects of some retinol binding protein-4 (RBP4) single nucleotide polymorphisms (SNPs) on the risk of gestational diabetes mellitus (GDM). In addition, the SNPs were examined for their possible association with insulin resistance at 6 weeks after delivery.

methodsThis was a prospective study of 100 women with GDM and 100 participants with normal gestation who were evaluated at gestational week 30 and 6 weeks postpartum. Three SNPs of RBP4 (rs3758539, rs116736522, and rs34571439) were genotyped using TaqMan assay. The genotype distributions between GDM patients and normal controls were analyzed using logistic regression models. In addition, differences in clinical characteristics among subjects grouped by genotype were assessed using the analysis of covariance test.

resultsThe frequencies of the rare alleles were not significantly different between GDM patients and controls. However, we identified two variants rs3758539 and rs34571439 associated with insulin levels and insulin resistance in women with previous GDM.

conclusionNoncoding SNPs of the RBP4 gene are not associated with GDM, but two SNPs showed associations with insulin resistance and insulin levels in women with prior GDM. Additional studies with increased sample size will be necessary in other GDM cohorts.

Indexed as

Polymorphism, Single NucleotideAdultCase-Control StudiesDiabetes, GestationalFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHomozygoteHumansInsulin ResistanceLinkage DisequilibriumPregnancyProspective StudiesRetinol-Binding Proteins, PlasmaSequence Analysis, DNARBP4 protein, humanRetinol-Binding Proteins, Plasma

Identifiers

PMID24665145
PMCPMC3934384
OpenAlexW2034100929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.